Orthostatic hypotension in patients with Parkinson's disease: Pathophysiology and management

Drugs and Aging

Volumn 18, Issue 7, 2001, Pages 495-505

  Senard, J M ^a   Brefel Courbon, C ^a   Rascol, O ^a   Montastruc, J L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; DESMOPRESSIN; FLUDROCORTISONE; MIDODRINE; OCTREOTIDE; THREO 3,4 DIHYDROXYPHENYLSERINE; YOHIMBINE;

COGNITION; ELDERLY CARE; HUMAN; LEWY BODY; MEDICAL DECISION MAKING; MORTALITY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034913776     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118070-00003     Document Type: Review

References (62)

1. Postural hypotension and postural dizziness in elderly women: The study of osteoporotic fractures
2. Orthostatic hypotension in the older adults: The cardiovascular health study
3. Prevalence predisposing factors, and prognosis importance of postural hypotension
4. Postural hypotension and EEG variables predict cognitive decline: Results from a 5-year follow-up of healthy elderly women
5. Orthostatic hypotension predicts mortality in elderly men: The Honolulu heart program
6. Prognosis of diastolic and systolic orthostatic hypotension in older persons
7. Autonomic nervous system disturbances in Parkinson's disease
8. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy
9. Overlooking orthostatic hypotension with routine blood pressure equipment
10. Ambulatory blood pressure monitoring in the study of autonomic dysfunction
11. Introduction and classification of autonomic disorders
12. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathological study
13. Consensus statement on the diagnosis of multiple system atrophy
14. Etude anatomoclinique d'un cas d'hypotension orthostatique idiopathique
15. Autonomic nervous system dysfunction in Parkinson's disease: Relationship with age, medication, duration and severity
16. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study
17. Prevalence of orthostatic hypotension in Parkinson's disease
18. Lewy bodies in thevisceral autonomic nervous system in Parkinson's disease
19. Adrenergic supersensitivity in parkinonsonians wih orthostatic hypotension
20. Distinction of Parkinson's disease from multiple system atrophy by stimulation of growth-hormone release with clonidine
21. Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson's disease or multiple system atrophy
22. 123I]MIBG separates Parkinson's disease from multiple system atrophy
23. Cardiac sympathetic denervation from the early stage of Parkinson's disease: Clinical and experimental studies with radiolabeled MIBG
24. Drug-induced orthostatic hypotension in the elderly: Avoiding its onset
25. Fluoxetine in orthostatic hypotension of Parkinson's disease: A clinical and experimental pilot study
26. Cardiovascular reflexes in Parkinson's disease: Long term effects of levodopa treatment on de novo patients
27. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease
28. Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease
29. The effect of catachol-o-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's disease
30. Management of postural hypotension
31. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency
32. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: A randomized, placebo-controlled, cross-over trial
33. Lack of yohimbine effect on ambulatory blood pressure recording: A double-blind cross-over trial in parkinsonians with orthostatic hypotension
34. Treatment of severe orthostatic hypotension by metoclopramide
35. Metoclopramide alone or combined with flurbiprofen in the treatment of orthostatic hypotension associated with diabetes mellitus
36. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension
37. Domperidone in the management of orthostatic hypotension
38. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease
39. Midodrine: A review of its therapeutic use in the management of orthostatic hypotension
40. Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine
41. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension
42. Clinical practice survey of midodrine prescribing in a universitary hospital
43. Etilefrine in the treatment of levodopa-induced orthostatic hypotension
44. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment
45. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
46. Phenylpropanolamine and the risk of hemorrhagic stroke
47. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin
48. Treatment of orthostatic hypotension with sleeping in the head-up tilt position and in combination with fludrocortisone
49. Levodopa-induced postural hypotension: Treatment with fludrocortisone
50. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone
51. Effect of bilateral section of splanchnic nerve on erythropoiesis
52. Treatment of orthostatic hypotension with erythropoietin
53. Erythropoietin treatment for postural hypotension from autonomic dysfunction
54. Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy and pure autonomic failure
55. Postprandial hypotension and parkinsonian state in Parkinson's disease
56. Postprandial hypotension: Pathophysiological mechanisms and clinical implications in different disorders
57. Haemodynamic and humoral effects of caffeine in autonomic failure: Therapeutic implications for postprandial hypotension
58. Haemodynamic and neurohumoral effects of caffeine in elderly patients with symptomatic postprandial hypotension: A double-blind, randomized, placebo-controlled study
59. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
60. Somatostain analog octreotide (SMS 201-995) prevents the decrease in blood pressure after oral glucose loading in the elderly
61. Octreotide in the management of orthostatic hypotension in multiple system atrophy: Pilot trial of chronic administration
62. Treatment of orthostatic hypotension with midodrine and octreotide